Founder and Clinical Lead

Jennifer Dore, MD is a board certified psychiatrist specializing in psychodynamic psychotherapy and medication management for conditions such as depression, anxiety, bipolar disorder, ADHD and addiction.  She currently serves on the board of the Ketamine Research Foundation.  Dr. Dore earned her MD from New York Medical College in 2007, with the highest academic distinction, Alpha Omega Alpha and holds a B.A. from Amherst College where she majored in English Literature.  Upon graduating, Dr. Dore trained for three years as a surgical resident at Weill Cornell/NY Presbyterian Hospital.  

Dr. Dore's training subsequently took her to Northern California where she joined the Stanford Department of Psychiatry as a resident physician.  While at Stanford, Dr. Dore's focus included the treatment of bipolar disorder, intensive individual psychotherapy, psychopharmacology, family and couples therapy, and medical decision making.   Dr. Dore's research in the area of bipolar disorder earned her recognition from the American Psychiatric Association during their 2013 Annual Meeting in San Francisco.  Dr. Dore was also elected Chief Resident for her contributions as a leader and innovator.  

In 2014, Dr. Jennifer Dore founded Helios Psychiatry with a mission to serve the local Bay Area community and innovate across a broad spectrum of traditional and pioneering treatments, including Ketamine-Assisted Psychotherapy.  Dr. Dore has worked with hundreds of patients and published numerous research papers including, most recently, a groundbreaking study into the effects of Ketamine-Assisted Psychotherapy published in the Journal of Psychoactive Drugs.